Clinical Value Analysis

AHSCA supports it's Members through a robust Clinical Value Analysis (CVA) program that serves as a the clinical interface between supply chain staff, clinicians, and organizational leaders. The CVA Team utilizes a systematic and objective process to evaluate the quality, safety, and value of supplies used to diagnose and treat patients. Specifically, the CVA process is led by CVA Facilitators focused on the following:

• Facilitates the work of the Product Enhancement/Product Standardization (PEPS) Teams and other ad-hoc Physician/Clinicals Teams, as needed, to drive both value and compliance
• Evidence-based, patient-centered, customer-focused, structured rationale that includes all key stakeholders in the decision-making process
• Goal-oriented approach ensuring the right product functions as designed
• Ensures that products purchased will support quality patient care in a fiscally responsible manner
• Drives standardization and utilization of products that maintain or improve the safety and quality of patient care
• Coordinates with local regional and member clinical and CVA teams

Utilizing the processes outlined above, the AHSCA CVA Team annually reviews and supports a significant volume of contracts, projects/category initiatives, and new product requests alongside the AHSCA Contracts Team. The CVA team is comprised of a Director of CVA/PPI and several CVA Facilitators who are all registered nurses of various clinical backgrounds with over 120 years of combined nursing experience.